Table II.

Top 30 differentially methylated sites in AML cells treated with decitabine compared with those treated with cytarabine.

Methylation	Log(fold-change)	P-value
cg22040989	−0.46477	7.71×10−27
cg19098118	−0.32461	3.17×10−22
cg14063817	−0.34161	1.51×10−19
cg17631454	−0.33468	5.13×10−19
cg02597199	−0.32804	1.82×10−18
cg08071595	−0.35059	3.15×10−18
cg27576136	−0.20948	1.73×10−17
cg09374462	−0.25800	1.77×10−17
cg12442125	−0.35154	4.70×10−17
cg05592278	−0.31725	4.70×10−17
cg27052900	−0.24157	4.70×10−17
cg22802167	−0.26297	5.69×10−17
cg08550094	−0.35068	6.61×10−17
cg21486341	−0.20684	6.79×10−17
cg08411833	−0.27190	8.08×10−17
cg17806847	−0.25718	8.08×10−17
cg03865944	−0.20673	9.44×10−17
cg03611733	−0.21888	9.80×10−17
cg12091641	−0.31272	1.43×10−16
cg17338368	−0.24704	2.00×10−16
cg23641672	−0.21018	2.87×10−16
cg23836413	−0.20551	2.87×10−16
cg05073880	−0.22513	3.63×10−16
cg12866103	−0.29918	5.32×10−16
cg03282689	−0.25659	6.36×10−16
cg07042346	−0.24842	8.04×10−16
cg09014775	−0.21864	8.09×10−16
cg05303739	−0.20861	1.05×10−15
cg11017535	−0.24066	1.51×10−15
cg13987334	−0.23196	1.51×10−15